Miriam Komaromy, MD, medical director for the Grayken Center for Addiction at BMC, reacts to the news of increased access to a key medication for opioid use disorder.
Substance Use Disorder
Practical challenges and stigma must be overcome for such an effort to succeed, but success could yield a blueprint for future care.
As the pandemic surges, the urgency of adjusting to find the most useful approach to SUD treatment in a critical population is growing.
Opioid overdose deaths in youth increasingly involve cocaine and other substances rather than opioids alone, research finds.